Sloan L, Sen R, Liu C, Doucet M, Blosser L, Katulis L
Front Immunol. 2024; 15:1438044.
PMID: 39346903
PMC: 11427284.
DOI: 10.3389/fimmu.2024.1438044.
Wang X, Zhang H, XinZhang , Liu Y
Biomark Res. 2024; 12(1):98.
PMID: 39228005
PMC: 11373306.
DOI: 10.1186/s40364-024-00628-3.
Su C, Kent C, Pierpoint M, Floyd W, Luo L, Williams N
JCI Insight. 2024; 9(14).
PMID: 39133651
PMC: 11383182.
DOI: 10.1172/jci.insight.178767.
Yang L, Cui X, Wu F, Chi Z, Xiao L, Wang X
Front Immunol. 2024; 15:1392499.
PMID: 38846948
PMC: 11154111.
DOI: 10.3389/fimmu.2024.1392499.
Bruss C, Albert V, Seitz S, Blaimer S, Kellner K, Pohl F
Front Immunol. 2024; 15:1355130.
PMID: 38742103
PMC: 11089195.
DOI: 10.3389/fimmu.2024.1355130.
Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma.
Su C, Kent C, Pierpoint M, Floyd W, Luo L, Wiliams N
bioRxiv. 2024; .
PMID: 38260522
PMC: 10802286.
DOI: 10.1101/2024.01.03.573968.
T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies.
Nenclares P, Larkeryd A, Manodoro F, Lee J, Lalondrelle S, Gilbert D
Front Oncol. 2024; 13():1296948.
PMID: 38234396
PMC: 10791873.
DOI: 10.3389/fonc.2023.1296948.
Synergistic treatment strategy: combining CAR-NK cell therapy and radiotherapy to combat solid tumors.
He J, Yan Y, Zhang J, Wei Z, Li H, Xing L
Front Immunol. 2024; 14:1298683.
PMID: 38162672
PMC: 10755030.
DOI: 10.3389/fimmu.2023.1298683.
Radiotherapy, photodynamic therapy, and cryoablation-induced abscopal effect: Challenges and future prospects.
Ali Mohammad S, Hak A, Pogu S, Rengan A
Cancer Innov. 2023; 2(5):323-345.
PMID: 38090387
PMC: 10686191.
DOI: 10.1002/cai2.53.
Modulation of CD8 T Cell Responses by Radiotherapy-Current Evidence and Rationale for Combination with Immune Checkpoint Inhibitors.
Jeon S, Song C, Eom K, Kim I, Kim J
Int J Mol Sci. 2023; 24(23).
PMID: 38069014
PMC: 10706388.
DOI: 10.3390/ijms242316691.
Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities.
Maccari M, Baek C, Caccese M, Mandruzzato S, Fiorentino A, Interno V
Oncologist. 2023; 29(4):289-302.
PMID: 38048782
PMC: 10994265.
DOI: 10.1093/oncolo/oyad321.
Opportunities and challenges in combining immunotherapy and radiotherapy in esophageal cancer.
Zhang X, Cai X, Yan C
J Cancer Res Clin Oncol. 2023; 149(20):18253-18270.
PMID: 37985502
PMC: 10725359.
DOI: 10.1007/s00432-023-05499-z.
DNA as the main target in radiotherapy-a historical overview from first isolation to anti-tumour immune response.
Frey B, Borgmann K, Jost T, Greve B, Oertel M, Micke O
Strahlenther Onkol. 2023; 199(12):1080-1090.
PMID: 37620671
DOI: 10.1007/s00066-023-02122-5.
Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition.
Noonepalle S, Grindrod S, Aghdam N, Li X, Gracia-Hernandez M, Zevallos-Delgado C
Mol Cancer Ther. 2023; 22(12):1376-1389.
PMID: 37586844
PMC: 10878032.
DOI: 10.1158/1535-7163.MCT-23-0215.
Radio-immune response modelling for spatially fractionated radiotherapy.
Cho Y, Yoon N, Suh J, Scott J
Phys Med Biol. 2023; 68(16).
PMID: 37459862
PMC: 10409909.
DOI: 10.1088/1361-6560/ace819.
Harnessing the abscopal effect for gastrointestinal malignancies in the era of immunotherapy.
Hino C, Lee E, Yang G
J Gastrointest Oncol. 2023; 14(3):1613-1625.
PMID: 37435204
PMC: 10331744.
DOI: 10.21037/jgo-23-105.
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer.
Jhawar S, Wang S, Thandoni A, Bommareddy P, Newman J, Marzo A
J Immunother Cancer. 2023; 11(7).
PMID: 37433716
PMC: 10347455.
DOI: 10.1136/jitc-2023-006780.
Targeted immune activation in pediatric solid tumors: opportunities to complement local control approaches.
Vonderhaar E, Dwinell M, Craig B
Front Immunol. 2023; 14:1202169.
PMID: 37426669
PMC: 10325564.
DOI: 10.3389/fimmu.2023.1202169.
Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy.
OLeary K, Bates A, Jin W, Burkel B, Sriramaneni R, Emma S
Breast Cancer Res. 2023; 25(1):68.
PMID: 37312163
PMC: 10265911.
DOI: 10.1186/s13058-023-01671-y.
Optimum fractionation of radiation to combine PD-1 blockade.
Teng F, Yin T, Ju X, Wang P, Wang Y, Yu J
MedComm (2020). 2023; 4(3):e271.
PMID: 37206639
PMC: 10188465.
DOI: 10.1002/mco2.271.
